Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Download
Standard view
Full view
of .
Look up keyword
Like this
21Activity
0 of .
Results for:
No results containing your search query
P. 1
Scrips America, The Perfect Place at the Perfect Time By: CBstock67

Scrips America, The Perfect Place at the Perfect Time By: CBstock67

Ratings: (0)|Views: 661 |Likes:
Published by Omerta Vendetta
A brief overview of upcoming catalyst that could potentially skyrocket the share price of ScripsAmerica a generic drug distribution company. With government contracts in hand coupled with cutting edge technology things are beginning to look up for this unknown company.
A brief overview of upcoming catalyst that could potentially skyrocket the share price of ScripsAmerica a generic drug distribution company. With government contracts in hand coupled with cutting edge technology things are beginning to look up for this unknown company.

More info:

Categories:Types, Research
Published by: Omerta Vendetta on Jun 03, 2013
Copyright:Attribution Non-commercial

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as DOCX, PDF, TXT or read online from Scribd
See more
See less

08/03/2013

pdf

text

original

 
Scripts America, The Perfect Place at the Perfect Time
As we move into the summer, trends in the market tend to stagnate and churn prior to once againramping back up towards it close and fall begins. Capitalizing on the this lull in the market canseem to be a daunting task. Most may enjoy the fresh summer breeze and the celebration of our country's independence gazing at the sky during the Fireworks in July; however there are otherswho are diligently working on building there empire in a emerging market space. Although the pace slows down for some, it is quite the contrary for startups, as it presents a multitude of unique opportunities to establish and make a name for themselves by marketing products soon to be hitting shelves when children return to school in the fall.
ScripsAmerica
has been patiently waiting in the shadows to take advantage of a recentloss in market share by Johnson & Johnson over the past few years after having their product for a melt able Tylenol pulled from shelves.. As I have been diligently researching and looking to place my initial investment in SCRC I started looking to the past to see where the future isheaded for ScripsAmerica and the
RapiMed™ 
product line in stores this fall. Johnson and
Johnson in 2008 was forced to recall their Tylenol™ product that had inaccurate dosing which
 resulted in liver damage amongst others as well. For the past 5 years J&J have been on amission to re-establish their product line and manufacturing facility in order to regaincomposure and sentiment with consumers. However this process has been a long haul and hadseveral failed attempts.
 
 
ScripsAmerica seems to be on the verge of cranking up their marketing campaign andimplementing their business model to better penetrate void in this space. Recently there have been several exciting and key pieces of news that lead me to believe something larger is at hand.Over the past few weeks we have seen notable news of manufacturing agreements withCapricorn Pharmaceuticals, whom is an extremely reputable manufacturer and holder of the patent for the rapid dissolving ODT (Oral Disintegrating tablet) technology. Teamed withCapricorn SCRC has the opportunity to revolutionize the delivery of not only Acetaminophen but also many other drugs for pharmaceutical companies looking to extend the life and patent of their FDA approved drugs. In other recent news negotiations of financing with a Hong KongBanking Syndicate it seems SCRC is set to explode in a move up with an attractive low float (8million) and low amount of outstanding shares (61,000,00).If my research is correct it seems that ScripsAmerica made the right choice down theshort path to stardom and profitability in 2013. The benefit that ScripsAmerica seems to reallyhave, is its leverage in the market because of the technology Capricorn can provide. There areseveral different methods for administration for oral delivery doses and they are targeted towardsa specific demographic. Those p
 
roducts formulated specifically for children, adolescents, youngadults and geriatric consumer markets are the fastest-growing category of Rx drugs. The FDAis, and has been granting exclusivity to many drugs that are good for therapeutic categories such
as Cancer, AIDS, Diabetes, Cardiovascular, CNS, and Alzheimer’. Patients can use better dosage
forms such as ODD for good taste and for taking the drug without the use of water. Rapiddispersible tablets, Rapidmelt and Disperse beads are some of the forms available in ODD. Thesedosage forms disperse in ten to twenty seconds in oral cavity without water. ScripsAmerica as of May, 2013 signed a manufacturing agreement with Capricorn which utilizes and is the inventor of the following forms of administration.
• Rapid Dispersible Tablet (RDT)
 
- Proprietary formulation with special compressiontechnology, to produce tablets that dissolve within 10 to 20 seconds in oral cavity.Technology is applicable to small and large dose drugs and taste masked ingredients areused. These robust tablets can be packaged in bottles or other packages. Ready for commercialization and product applications.
 
Rapid Melt Beads (RMB)
-
 A solid emulsion melt system in beads form with quick-melt (less than 5 seconds), salivating and smooth textured. The system does not containany moisture and the process is performed at low temperature. Applicable to broad range of actives and dosages including Anti-infectives and Antibiotics. Taste masked ingredients
areused. Ready for commercialization and product applications.
 
Disperse Beads (DAB)
-
 A matrix system in beads or powder form, readily dispersibleor reconstituted in water for unit or multiple dosage administration. Suitable for Antibioticssuch as Amoxicillin, Ampicillin, Cephalosporins, Macroloides such as Clarithromycin, Azithromycin, Erythromycin and Moisture sensitive actives such as Potassium Clavulinate,Lactic Acid Bacillus etc. Ready for commercialization and product applications.
 
D-Zolv (DZ)
-
 A fast disintegrating solid dosage form based on a proprietary processingtechnology. The tablets dissolve in less than 15 seconds and require unit dosage packaging.Ready for broad product applications and scale-up.
 
 
 
Healthee Chew (HC 
 )
- A soft, non-sugar, diabetic friendly proprietary formulation and  process for a chewable, salivating, juicy and good tasting dosage form. Formed and  packaged with accurate piece weight, providing quick or longer disintegration in the mouth.Commercialized and ready for a broad range of actives small, and large dosages.
ScripsAmerica is working to focus on the Rapid Melt method and has already
incorporated the following into the RapiMed™ product line. This method
carries severaladvantages moving forward as it allows for the following.
 
Rapid Release Fast Dissolving Tablets
 
High Profit Margins
 
Spanish and English On Packaging
 
No Water Needed
 
Dissolves In Mouth In 15-20 Seconds
 
Fruit Flavors-Cherry, Wild Grapeystem
 
Overcomes Objection To Taking Pills
 
Accurate Dosing
 
Faster Absorption in to the system
In 2012 Drug Store News reported RapiMed as one of the hottest and top 10products of the "Over the Counter ECRM Cough and Cold Show" , held in Las Vegasevery year
 
RapiMed™
is a very well marketed and developed product and should really create a stir in September when products start to ship. With
RapiMed™
having received 500,000 in financing

Activity (21)

You've already reviewed this. Edit your review.
1 hundred reads
1 thousand reads
Omerta Vendetta liked this
Omerta Vendetta liked this
Omerta Vendetta liked this
Omerta Vendetta liked this
Omerta Vendetta liked this
Omerta Vendetta liked this
Omerta Vendetta liked this
Omerta Vendetta liked this

You're Reading a Free Preview

Download
scribd
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->